Alterity Therapeutics (ATHE) said on Monday it appointed Abby Niven to succeed Phillip Hains as chief financial officer, effective today.
Niven has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett and consults on governance, finance, and corporate structure for various companies.
Hains continues as company secretary.